Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 75% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 1 | 13% |
Developing RNAi therapeutics for Hepatitis B and C, using eiRNA technology
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 75% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 1 | 13% |